Assessing residual lipid risk with advanced testing
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Hyperlipidemia
Icosapent ethyl in post-CABG patients with diabetes
Subodh Verma, MD, PhD
- Hyperlipidemia
Phase 3 study results of plozasiran in patients with FCS
Gerald F. Watts, DSc, DM, PhD
- ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
C. David Mazer, MD
- ESC Congress 2024
Lp(a) in patients with recent CHD
Prof. Kausik Ray, MBChB, MD, MPhil